Cite
HARVARD Citation
Andrikopoulou, A. et al. (n.d.). 2022-RA-1607-ESGO Optimal time interval between neoadjuvant platinum-based chemotherapy and interval debulking surgery. International journal of gynecological cancer. pp. A353-A354. [Online].